Histone H2B type 1-C/E/G | Q6ZWY9 | 8.8e-5 | 4.9e-1 | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007 Jun;9(6):654-9. Epub 2007 May 7. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-P | Q8CGP2 | 1.1e-4 | 4.9e-1 | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007 Jun;9(6):654-9. Epub 2007 May 7. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (H2b 613) | Q64524 | 2.0e-7 | 4.0e-1 | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007 Jun;9(6):654-9. Epub 2007 May 7. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | B2R4S9 | 2.4e-9 | 3.8e-1 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n) | P23527 | 4.3e-5 | 4.9e-1 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q) | Q16778 | 2.0e-14 | 2.9e-1 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q) | Q16778 | 1.2e-5 | 4.7e-1 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 3-B (H2B type 12) | Q8N257 | 7.3e-8 | 4.1e-1 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008 Dec;10(12):1470-6. doi: 10.1038/ncb1800. Epub 2008 Nov 16. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) | P62807 | 1.2e-7 | 2.1e-1 | Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009 May;20(5):1053-67. doi: 10.1681/ASN.2008070798. Epub 2009 Apr 23. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 9.4e-4 | Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009 May;20(5):1053-67. doi: 10.1681/ASN.2008070798. Epub 2009 Apr 23. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n) | P23527 | 0.0e+0 | 3.4e-6 | Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009 May;20(5):1053-67. doi: 10.1681/ASN.2008070798. Epub 2009 Apr 23. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 3-B (H2B type 12) | Q8N257 | 2.5e-8 | 1.7e-1 | Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009 May;20(5):1053-67. doi: 10.1681/ASN.2008070798. Epub 2009 Apr 23. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 2.7e-1 | Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics. 2009 Nov 25;10:556. doi: 10.1186/1471-2164-10-556. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 3.6e-1 | Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics. 2009 Nov 25;10:556. doi: 10.1186/1471-2164-10-556. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q) | Q16778 | 0.0e+0 | 4.5e-1 | Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics. 2009 Nov 25;10:556. doi: 10.1186/1471-2164-10-556. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | M0R4L7 | 0.0e+0 | 1.5e-1 | Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 2010 Feb 15;70(4):1668-78. doi: 10.1158/0008-5472.CAN-09-2470. Epub 2010 Feb 2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | M0R4L7 | 0.0e+0 | 2.4e-1 | Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 2010 Feb 15;70(4):1668-78. doi: 10.1158/0008-5472.CAN-09-2470. Epub 2010 Feb 2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/G | Q6ZWY9 | 0.0e+0 | 2.9e-1 | Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun. 2010 Aug 6;398(4):723-9. doi: 10.1016/j.bbrc.2010.07.008. Epub 2010 Jul 17. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K | Q8CGP1 | 0.0e+0 | 3.4e-1 | Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun. 2010 Aug 6;398(4):723-9. doi: 10.1016/j.bbrc.2010.07.008. Epub 2010 Jul 17. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K | Q8CGP1 | 0.0e+0 | 3.0e-1 | Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun. 2010 Aug 6;398(4):723-9. doi: 10.1016/j.bbrc.2010.07.008. Epub 2010 Jul 17. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (H2b 613) | Q64524 | 0.0e+0 | 4.7e-1 | Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun. 2010 Aug 6;398(4):723-9. doi: 10.1016/j.bbrc.2010.07.008. Epub 2010 Jul 17. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | B2R4S9 | 0.0e+0 | 4.8e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | B2R4S9 | 0.0e+0 | 4.5e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | B2R4S9 | 0.0e+0 | 4.9e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-H (Histone H2B.j) (H2B/j) | Q93079 | 0.0e+0 | 4.6e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 4.8e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-L (Histone H2B.c) (H2B/c) | Q99880 | 0.0e+0 | 4.0e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-M (Histone H2B.e) (H2B/e) | Q99879 | 0.0e+0 | 4.8e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-N (Histone H2B.d) (H2B/d) | Q99877 | 0.0e+0 | 4.3e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n) | P23527 | 0.0e+0 | 4.7e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q) | Q16778 | 0.0e+0 | 4.8e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 3-B (H2B type 12) | Q8N257 | 0.0e+0 | 4.5e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B | B2R4S9 | 0.0e+0 | 4.8e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-L (Histone H2B.c) (H2B/c) | Q99880 | 0.0e+0 | 4.3e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-N (Histone H2B.d) (H2B/d) | Q99877 | 0.0e+0 | 4.3e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q) | Q16778 | 0.0e+0 | 4.9e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 3-B (H2B type 12) | Q8N257 | 0.0e+0 | 4.6e-1 | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012 Jan 17;12:22. doi: 10.1186/1471-2407-12-22. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-F/J/L (H2B 291A) | P10853 | 0.0e+0 | 3.5e-1 | Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One. 2012;7(4):e34653. doi: 10.1371/journal.pone.0034653. Epub 2012 Apr 10. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 3.6e-1 | Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 6.4e-13 | 4.3e-1 | Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 4.7e-2 | 8.9e-2 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 4.3e-2 | 9.1e-2 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) | P62807 | 3.1e-2 | 2.4e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r) | P06899 | 4.6e-2 | 3.5e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n) | P23527 | 4.8e-2 | 3.6e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 1.5e-2 | 1.2e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) | P62807 | 3.4e-2 | 1.4e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r) | P06899 | 3.9e-2 | 1.7e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 3.0e-2 | 1.2e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 1.1e-16 | 4.7e-1 | First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 3.3e-16 | 4.8e-1 | First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-F | Q5QNW6 | 0.0e+0 | 4.0e-1 | First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 4.5e-1 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r) | P06899 | 0.0e+0 | 4.2e-1 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 4.5e-1 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r) | P06899 | 0.0e+0 | 4.7e-1 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 1.3e-12 | 3.0e-1 | Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-B (H2b 616) | Q64525 | 0.0e+0 | 1.8e-1 | Growth factor stimulation of cardiomyocytes induces changes in the transcriptional contents of secreted exosomes. J Extracell Vesicles. 2013 May 17;2. doi: 10.3402/jev.v2i0.20167. eCollection 2013. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) | P62807 | 0.0e+0 | 4.5e-1 | Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 2016 Oct 28:0. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 8.7e-2 | Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 2016 Oct 28:0. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-L (Histone H2B.c) (H2B/c) | Q99880 | 0.0e+0 | 1.6e-1 | Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 2016 Oct 28:0. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) | P62807 | 0.0e+0 | 1.1e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 4.7e-2 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 1.1e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r) | P06899 | 0.0e+0 | 4.3e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 3.1e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 1.2e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) | P62807 | 0.0e+0 | 2.1e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 9.3e-2 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b) | P58876 | 0.0e+0 | 2.4e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1) | O60814 | 0.0e+0 | 4.1e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |
Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q) | Q16778 | 0.0e+0 | 4.9e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111NV5 | 26 / 0 / 26 |